When and Whom To Screen

Letters1 December 1993When and Whom To ScreenThomas E. Lindow, MDThomas E. Lindow, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-119-11-199312010-00025 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Schapira and colleagues [1] noted that screening with the combination of CA 125 and ultrasound prolongs life by less than a day per woman screened. Pauker [2] pointed out that such screening prolongs the lives of those found to have preclinical cancer by 11.6 years each. Nevertheless, he goes on to say, such (screening) programs cannot be recommended as public policy [2].Why do they disregard an astounding 11.6-year prolongation of life and concentrate instead on the misleading less-than-1-day statistic?A woman does not need a scientific study to tell her that a clean bill of health ...References1. Schapira MM, Matchar DB, Young MJ. The effectiveness of ovarian cancer screening: a decision analysis model. Ann Intern Med. 1993; 118:838-43. Google Scholar2. Pauker SG. Deciding about screening. Ann Intern Med. 1993; 118: 901-2. Google Scholar Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byHow Changes in Health Care Practices, Systems, and Research Challenge the Practice of Informed Consent 1 December 1993Volume 119, Issue 11Page: 1150-1152KeywordsCancer screeningLaparotomyLife expectancyOvarian cancer screeningPublic policyUltrasound imaging ePublished: 15 August 2000 Issue Published: 1 December 1993 Copyright & PermissionsCopyright © 1993 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...